Stock search

Ticker or company name

Compare stocks

Market: US

  • CAHCardinal Health
  • BSXBoston Scientific
  • CORCencora

Add stock

Ticker or company

Summary

CAH
Cardinal Health
$283,85Up +0,98%
Year: Up +36%

Not enough data for a score

Open stock page
BSX
Boston Scientific
$43,69Down −1,47%
Year: Down −58%
83/100Best scoreRatio would consider buying
Open stock page
COR
Cencora
$356,94Down −0,58%
Year: Down −4%
83/100Best scoreRatio would consider buying
Open stock page

Verdict

BSX has the best score (83). CAH grows revenue the fastest. BSX is the cheapest by forward P/E. BSX has the lowest debt load. BSX has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCAH1 ✓ 0 — 2 ✕BSX6 ✓ 3 — 0 ✕COR6 ✓ 3 — 0 ✕
P/E vs its history35,718,419,7
P/E vs industry35,718,419,7
Forward P/E19,214,016,8
Revenue growth, YoYn/a—+8,9%+5,1%
EPS growth, YoYn/a—+26,2%+38,3%
Net marginn/a—16,6%0,8%
Net debt / EBITDAn/a—−0,12,4
Free cash flown/a—$3,33 bn$4,06 bn
Share count over a yearn/a—−2,9%−0,7%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCAHTTMBSXTTMCORTTMIndustry medianTTM
P/E TTM ↓Worst: 35,7Best: 18,419,725,1
Forward P/E ↓Worst: 19,2Best: 14,016,816,2
PEG ↓Worst: 3,1Best: 0,72,42,2
P/S TTM ↓0,3Worst: 3,1Best: 0,22,2
EV/EBITDA ↓Worst: 23,215,6Best: 15,117,3
P/FCF ↓13,3Worst: 19,3Best: 10,919,5

Price, %

  • CAHn/a
  • BSXn/a
  • CORn/a

Returns

Best WorstNo mark — in between

PeriodCAHBSXCOR
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CAHBSXCOR
Share of “buy”Best: 86%Worst: 65%70%
Beat the forecastBest: 4 of 4Best: 4 of 4Worst: 3 of 4
Average “surprise”Best: +9,5%+1,5%Worst: +0,1%
Insiders over 12 monthssales $61,6 msales $6,76 msales $13,1 m

Details are on each stock page.